A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation

Clinical trial NCT06081829 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06081829
Sponsor: Servier
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma Non-resectable Cholangiocarcinoma Metastatic

Start date: 2023-10-10
Primary completion: 2024-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.